| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/17/1996 | US5556754 Major histocompatibility complex, treatment of autoimmune diseases |
| 09/17/1996 | US5556753 DNA encoding human α1 adrenegric receptors and uses thereof |
| 09/17/1996 | US5556644 Nutritional supplement for the elderly |
| 09/17/1996 | US5556612 Methods for phototherapeutic treatment of proliferative skin diseases |
| 09/12/1996 | WO1996027386A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
| 09/12/1996 | WO1996027384A2 Composition for treating skin conditions comprising an inhibitor of skin iso-phosphodiesterase |
| 09/12/1996 | WO1996027378A2 Use of penciclovir for the treatment of human herpes-virus-8 |
| 09/12/1996 | WO1996020718A3 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin |
| 09/12/1996 | DE19516773A1 Use of DNA to prepare medicaments |
| 09/11/1996 | EP0730865A1 Use of serotonin and dopamine receptor blockers for the treatment of mental disorders associated with cerebrovascular disease |
| 09/11/1996 | EP0730862A1 Formulation containing glucaric acid for the prevention or treatment of non-cancerous cellular hyperproliferation and dietary supplement |
| 09/11/1996 | EP0730648A1 HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER |
| 09/11/1996 | EP0730606A1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR |
| 09/11/1996 | EP0730601A1 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections |
| 09/11/1996 | EP0730589A1 Isoxazoline compounds useful as fibrinogen receptor antagonists |
| 09/11/1996 | EP0730464A1 Composition comprising sulcralfate and an antimicrobial agent/ion-exchange resin complex |
| 09/11/1996 | EP0730458A1 Use of aldosterone antagonists to inhibit myocardial fibrosis |
| 09/11/1996 | EP0730455A1 Antiarrhythmic benzodiazepines |
| 09/11/1996 | EP0730453A1 Methods of treating cardiac arrhythmia |
| 09/11/1996 | EP0730451A1 Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis |
| 09/11/1996 | EP0730448A1 Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor |
| 09/11/1996 | EP0730446A1 Protein kinase c activators and their use in decreasing expression of cell antigens |
| 09/11/1996 | EP0730443A1 Suspension of loteprednol etabonate |
| 09/11/1996 | EP0534944B1 Antibodies specific for elam-1 and the use thereof |
| 09/11/1996 | EP0528950B1 Formula and method for the prevention and treatment of hypercholesterolemia and cellular hyperproliferative disorders |
| 09/11/1996 | CN1130876A Compounds for prevention and treatment of helminth infections |
| 09/11/1996 | CN1130874A Method of treating liver disease and like indications with vasodilating agents |
| 09/11/1996 | CN1130866A Anti-angiogenic compositions and method of use |
| 09/11/1996 | CN1130532A Modulation of cellular activity |
| 09/10/1996 | US5554654 Method for enhancing the therapeutic effect of an anti-acne agent |
| 09/10/1996 | US5554652 Topically applying mixture to reduce or prevent skin disorders |
| 09/10/1996 | US5554651 Method of treating wrinkles using citramalic acid |
| 09/10/1996 | US5554638 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders |
| 09/10/1996 | US5554628 Method for minimizing the uterothrophic effect of tamoxifen and tamoxifen analogs |
| 09/10/1996 | US5554623 Method for the long term reduction of body fat stores, insulin resistance, hypersinsulinemia and hyperglycemia in vertebrates |
| 09/10/1996 | US5554608 Inhibition of hair growth |
| 09/10/1996 | US5554597 Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging |
| 09/06/1996 | WO1996027009A1 Human amine transporter |
| 09/06/1996 | WO1996026738A1 Pharmaceutical compositions for controlled release of soluble receptors |
| 09/06/1996 | WO1996026724A1 Pharmaceutical compositions containing a benzydamine or its salt and an antimicrobial agent |
| 09/06/1996 | WO1996026720A1 Pharmaceutical compositions comprising monoamine oxidase b inhibitors |
| 09/06/1996 | WO1996026711A1 Nitric oxide synthase inhibitors |
| 09/06/1996 | WO1996021000A3 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 09/06/1996 | WO1996016647A3 Use of chloride channel blockers for reducing intraocular pressure |
| 09/06/1996 | CA2212101A1 Nitric oxide synthase inhibitors |
| 09/04/1996 | EP0729750A1 Use of an interleukin-1 antagonist and/or alpha-TNF antagonist in a cosmetic, pharmaceutical or dermatological composition, and the composition therefrom, possibly used in combination with a histamine antagonist |
| 09/04/1996 | EP0729359A1 A method for treating cardiac dysfunction and pharmaceutical compositions useful therefor |
| 09/04/1996 | EP0729356A1 Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases |
| 09/04/1996 | EP0355131B1 Acyl deoxyribonucleoside derivatives and uses thereof |
| 09/04/1996 | CN1130354A Compositions containing amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of decongestant an expectorant, an antihistamine and an antitussive |
| 09/04/1996 | CN1130352A Controlled-releasing opioid formulations for treating pain |
| 09/03/1996 | US5552558 Retroviral protease inhibiting compounds |
| 09/03/1996 | US5552429 Administering fluoxetine and pindolol to increase availability of serotonin, dopamine and norepinephrine |
| 08/29/1996 | WO1996026285A2 Methods and compositions for administering gene therapy vectors |
| 08/29/1996 | WO1996026275A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 08/29/1996 | WO1996026272A1 Prostate-specific membrane antigen and uses thereof |
| 08/29/1996 | WO1996025949A1 Compounds for preventing multidrug resistance in cancer cells containing protein kinase inhibitors |
| 08/29/1996 | WO1996025948A1 PREPARATION AND USE OF A SPECIFIC GABA-Aα5 RECEPTOR LIGAND FOR TREATMENT OF ALZHEIMER'S DISEASE |
| 08/29/1996 | WO1996025937A1 Cinnamoyl-c-glycoside chromone isolated from aloe barbadensis |
| 08/29/1996 | WO1996025936A1 2,6-diaryl pyridazinones with immunosuppressant activity |
| 08/29/1996 | WO1996025935A1 Method of treating adenosine depletion |
| 08/29/1996 | WO1996025931A2 Use of fused benzothiazoles as neuroprotectants |
| 08/29/1996 | WO1996025852A1 Composition for controlling parasites |
| 08/29/1996 | WO1996019580A3 Telomerase protein component |
| 08/29/1996 | WO1996016675A3 Composition for prevention and treatment of hiv-1 infection comprising at least two different hiv-1 reverse transcriptase inhibitors |
| 08/29/1996 | CA2213439A1 Methods and compositions for administering gene therapy vectors |
| 08/29/1996 | CA2213135A1 2,6-diaryl pyridazinones with immunosuppressant activity |
| 08/29/1996 | CA2212870A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 08/29/1996 | CA2212846A1 Prostate-specific membrane antigen and uses thereof |
| 08/29/1996 | CA2212525A1 Use of fused benzothiazoles as neuroprotectants |
| 08/29/1996 | CA2210320A1 Compounds for preventing multidrug resistance in cancer cells containing protein kinase inhibitors |
| 08/28/1996 | EP0728482A2 Use of hcp specific compounds to enhance erythropoiesis |
| 08/28/1996 | EP0728481A2 Use of quinoxaline and protease inhibitors in a composition for the treatment of AIDS and/or HIV infections |
| 08/28/1996 | EP0728009A1 Use of an agent which modulates tyrosine phosphorylation for modulating the permeability of a psychological barrier |
| 08/28/1996 | EP0728005A1 Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide |
| 08/28/1996 | EP0728000A1 The use of alfuzosin or terazosin in the treatment of premature ejaculation |
| 08/28/1996 | EP0727989A1 Butyric ester cyto-differentiating agents |
| 08/28/1996 | EP0727986A1 Treatment of migraine |
| 08/28/1996 | EP0727979A1 Novel composition |
| 08/28/1996 | EP0727978A1 Topical aromatic releasing compositions |
| 08/28/1996 | EP0523100B1 O6 -benzylated guanine, guanosine and 2'-deoxyguanosine compounds possessing o6 -alkylguanine-dna alkyltransferase depleting activity |
| 08/28/1996 | CN1129947A Polymeric matrices and their uses in pharmaceutical compositions |
| 08/28/1996 | CN1129941A Substituted azaindolylidene compounds and process for their preparation |
| 08/28/1996 | CA2170222A1 Use of quinoxalines in combination with protease inhibitors as medicaments for treating aids and/or hiv infections |
| 08/27/1996 | US5550188 Polymer conjugates ophthalmic devices comprising collagen-polymer conjugates |
| 08/27/1996 | US5550158 Method of treating wrinkles using glucoheptonic acid |
| 08/27/1996 | US5550154 Topical application |
| 08/27/1996 | US5550149 Sulfur-containing compounds that are effective in potentiating the activity of chemotherapeutic anti-cancer agents by increasing sensitivity of multi-drug resistant cells |
| 08/27/1996 | US5550124 Use of peripheral-type benzodiazpine sites for treatment of CNS trauma or disease |
| 08/27/1996 | US5550107 Anticarcinogenic agents and antiestrogens |
| 08/27/1996 | US5550050 Exposing cells enclosed in biocompatible capsules to restrictive environmental conditions which match those which will be encountered after implantation until desired responses are established |
| 08/27/1996 | US5550019 Methods of identifying compounds which alter apoptosis |
| 08/27/1996 | US5549915 Magnetically responsive composition for carrying biologically active substances and methods of production |
| 08/27/1996 | US5549901 Antimicrobial oil-in-water emulsions |
| 08/27/1996 | US5549888 Acidic mixtures containing salicyclic, retinoic, azelaic, lactic, glycolic or pyruvic acids, water soluble glycol ethers and nonionic surfactants |
| 08/27/1996 | CA2135890C Retroviral protease inhibitor (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4- thiazolyl)methyl)amino)carbonyl)valinyl)amino)- 2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1, 6-diphenyl-3-hydroxyhexane |
| 08/27/1996 | CA1338552C Use of asymmetric membranes in delivery devices |
| 08/22/1996 | WO1996025666A1 NF-λB ACTIVATION REGULATORY PROTEIN, IλB-BETA |
| 08/22/1996 | WO1996025502A1 Calcineurin regulatable adenylate cyclase |
| 08/22/1996 | WO1996025423A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity |